Neurology
Preventing Recurrent Ischemic Stroke With Heart-Brain Clinic
Recurrent ischemic stroke is one of the most devastating yet preventable medical problem.
Dr. Abu Bakar · June 28, 2026 · 6 min
Brain, nerve and cognitive care
Neurology
Neurology and neuroscience briefs covering diagnosis, disease-modifying therapy and long-term management.
Dr. Abu BakarContributing writer · PharmD, PhD (Pharmacology)
Neurology
Current Status of Retinal Diagnostics In Alzheimer’s Disease
The use of retinal markers for the early detection of biological changes in Alzheimer’s disease is becoming increasingly
Rayan Salih · 9 min read
Neurology
A 24-Year Mortality Analysis of Spinal Muscular Atrophy and a Blueprint for Future Pediatric Care
For generations of pediatricians, neonatologists, and pediatric neurologists, a diagnosis of Spinal Muscular Atrophy (SMA) Type 1 carried
Rayan Salih · 8 min read
Neurology
Bridging The Gap In Schizophrenia Care: Lessons From A National Analysis Of Medicaid Beneficiaries
Schizophrenia has long been recognized as one of the most complex, chronic, and debilitating challenges in modern psychiatry….
Rayan Salih · 11 min read
Neurology
Clinical Briefing: The Dawn of Non-Stigmatizing Seizure Detection
For patients with uncontrolled epilepsy, the threat of an unexpected seizure is a constant source of profound anxiety….
Rayan Salih · 9 min read
Neurology
Rethinking Migraine and Stroke Risk in Middle and Older Age
For decades, the clinical narrative surrounding migraine and stroke risk has been clear-cut, specific, and highly selective.
Rayan Salih · 8 min read
Neurology
2026 AAN Neurology Updates: The Changing Face of Neuroinfectious Disease
The landscape of neuroinfectious diseases is shifting beneath our feet.
Rayan Salih · 8 min read
Neurology
A New Era for Huntington’s Disease Care: 2026 AAN Key Takeaways
Huntington’s Disease (HD) represents one of the most challenging neurodegenerative conditions in modern medicine.
Rayan Salih · 8 min read
Neurology
Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression
Motif Neurotech has won FDA permission to start clinical testing of a tiny brain implant for treatment-resistant depression….
Dr. Abu Bakar · 6 min read
Neurology
The End of the “Wait and See” Era: How Blood Tests Are Revolutionizing Neurology
No longer are decades of misdiagnosis of Alzheimer’s disease acceptable.
Rayan Salih · 12 min read
Neurology
Fetal Alcohol Spectrum Disorder (FASD): Understanding Its Lifelong Mental Health Impact
The Fetal Alcohol Spectrum Disorder (FASD) is a lifelong brain disorder that results from alcohol consumption by pregnant
Dr. Abu Bakar · 7 min read
Neurology
Narcolepsy Comorbidities and Their Symptom Profiles: What Clinicians and Patients Should Know
Narcolepsy is a chronic neurological sleep disorder that rarely exists alone.
Dr. Abu Bakar · 6 min read
Neurology
Big Ideas from the 2026 American Academy of Neurology Annual Meeting (AAN): What’s Changing in Brain Health and Why It Matters
As in previous years the Annual Meeting of the American Academy of Neurology (AAN) was a large convention
Rayan Salih · 13 min read
Neurology
Wrap-Up: Vyvgart Targets Four Populations at AAN 2026
A Summary of the 2026 AAN Annual Meeting for Rare Diseases from a Managed Care Perspective – Myasthenia
Rayan Salih · 9 min read
Neurology
Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP
ADHERE post hoc data at AAN 2026 show 87.5% of treatment-naive CIDP patients respond early to Vyvgart Hytrulo, challenging IVIG step therapy.
Rayan Salih · 7 min read
Neurology
Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis
ADAPT Jr data show 80% of adolescent gMG patients achieved minimal symptom expression by cycle two with efgartigimod at AAN 2026.
Rayan Salih · 7 min read
Neurology
The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
Research to treat Alzheimer’s and other neurodegenerative diseases has been largely focused on removal of amyloid-beta plaques and
Rayan Salih · 10 min read
Neurology
Ocular Myasthenia Gravis Gets Its First Targeted Biologic Candidate
Phase 3 ADAPT OCULUS data at AAN 2026 show efgartigimod significantly improves ocular MG symptoms, supporting a planned FDA sBLA submission for the oMG indication.
Rayan Salih · 2 min read
Neurology
Vyvgart Crosses the Antibody Line in Seronegative Myasthenia Gravis
Phase 3 ADAPT SERON data at AAN 2026 show efgartigimod significantly improves MG-ADL scores in seronegative gMG patients, with FDA priority review targeting May 10, 2026.
Rayan Salih · 8 min read
Neurology
Low‑Dose Lithium for Mild Cognitive Impairment: What a Pilot Trial Shows About Safety and Feasibility
An early trial of the method involving lithium treatment in people with mild cognitive impairment (MCI) revealed that
Dr. Abu Bakar · 7 min read
Neurology
FDA Approves Avlayah In Hunter Syndrome Neurologic Manifestations
The U.S. Food and Drug Administration today approved Avlayah (tividenofusp alfa-eknm) for the management of central neurologic manifestations
Rayan Salih · 10 min read
Neurology
Phase 2b Biomarker Analysis: BCMA CAR-T in Myasthenia Gravis
CAR-T cells that have been redirected to B cell maturation antigen (BCMA) may also be useful for treating
Rayan Salih · 3 min read
Neurology
MIND Diet Adherence Linked to Slower Structural Brain Atrophy
The MIND diet may help ward off dementia, and a new study finds it may even slow down
Rayan Salih · 11 min read
Neurology
Acetylcholine Receptor-Positive Myasthenia Gravis in Older Patients
Acetylcholine receptor-positive myasthenia gravis (AChR-positive MG) is an autoimmune disease that leads to Fatigable weakness, often fluctuating in
Dr. Abu Bakar · 13 min read
Neurology
Self-Care, Self-Compassion Key To Reducing Clinician Burnout
Health care clinicians continue to feel significant levels of burnout.
Rayan Salih · 9 min read
Neurology
Psychosocial Symptoms Equal Motor Burden In Early Parkinson’s
Psychosocial problems (depression, anxiety, apathy, isolation, etc.) have become major disabling problems for people with early Parkinson’s disease….
Rayan Salih · 1 min read
Neurology
A New Biological Front in MS: Fenebrutinib For Primary Progressive Multiple Sclerosis (PPMS)
For decades, Multiple Sclerosis (MS) research focused heavily on relapsing forms of the disease, leaving patients with progressive
Rayan Salih · 7 min read
Neurology
Early Initiation of Anti-Amyloid Therapies Is Key To Alzheimer’s Care
Anti-amyloid therapies, specifically monoclonal antibodies like lecanemab and donanemab, represent a historic shift in Alzheimer’s disease (AD) care,
Rayan Salih · 8 min read
Neurology
Alzheimer’s Disease: Diagnosis, Biomarkers, Early Detection
While Alzheimer’s disease has a long clinical history, understanding of the disease now extends to the biological changes
Dr. Abu Bakar · 14 min read
Neurology
Fremanezumab Reduces Prolonged Sporadic Hemiplegic Migraine Rate
Fremanezumab is a human monoclonal antibody directed against calcitonin gene-related peptide (CGRP).
Dr. Abu Bakar · 15 min read
Neurology
Blood-Based Biomarkers Among Notable Alzheimer’s Advances
There is growing interest in the potential of blood-based biomarkers for Alzheimer’s disease to challenge current clinicians’ concepts
Rayan Salih · 9 min read
Neurology
Understanding Amyloid’s Role In Alzheimer’s Disease Pathology
Amyloid, specifically amyloid beta, is the most well-known biological feature of Alzheimer’s disease.
Dr. Abu Bakar · 11 min read
Neurology
Speed-Based Cognitive Training Lowers Alzheimer’s, Dementia Risk
More emphasis has been put on alternatives to medication, and some exercises may lower the risk of suffering
Rayan Salih · 1 min read
Neurology
Mitochondrial DNA Profiling in Blood and CSF for ALS Insights
Analysis of mitochondrial DNA (mtDNA) has revealed insights into the pathogenesis of amyotrophic lateral sclerosis (ALS).
Rayan Salih · 5 min read
Neurology
Strategies to Enhance Focus in ADHD Management
This series of Strategies continues from last issue. This series began in Vol. 19, No.
Dr. Abu Bakar · 9 min read
Neurology
Weak Body Clock May Signal Early Dementia Risk
Older adults with weak and variable body rhythms that control wakefulness may be more likely to develop dementia….
Dr. Abu Bakar · 9 min read
Neurology
Emotional Discomfort Linked to Poor Stroke Recovery Outcomes
Share emotions to aid stroke recovery. Expressing your fears and emotions after suffering a stroke is important to
Dr. Abu Bakar · 8 min read
Neurology
Distinct Molecular Subtypes in Alzheimer’s Disease Inform Personalized Treatment Strategies
The scientific study of Alzheimer’s Disease (AD) is on the cusp of a revolution as growing evidence demonstrates that
Dr. Abu Bakar · 8 min read
One story a day
The story of the day, in your inbox
One health journey each morning — no advice, no alarm, just company for the road.